Endothelial cells of human colorectal cancer and healthy colon reveal phenotypic differences in culture

Laboratory Investigation

Volumn 87, Issue 11, 2007, Pages 1159-1170

  Schellerer, Vera Simone ^a   Croner, Roland Siegfried ^a   Weinländer, Kristina ^a   Hohenberger, Werner ^a   Stürzl, Michael ^a   Naschberger, Elisabeth ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiogenesis; Colorectal cancer; Endothelial cells; Von Willebrand factor

Indexed keywords

CD31 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CYTOKERATIN 20; ENDOGLIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; PODOPLANIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR;

ACETYLATION; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL; CAPILLARY; CELL CULTURE; CELL ISOLATION; CELL LEVEL; CELL LINEAGE; CELL SELECTION; COLON; COLORECTAL CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; EPIGENETICS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAGNET; MALE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PURIFICATION; STAINING; TISSUE LEVEL; TUMOR VASCULARIZATION;

AGED; ANTIGENS, CD31; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELLS, CULTURED; COLON; COLORECTAL NEOPLASMS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR CELL ADHESION MOLECULE-1; VON WILLEBRAND FACTOR;

EID: 35348985981     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700671     Document Type: Article

References (24)

1. Quesada AR, Munoz-Chapuli R, Medina MA. Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev 2006;26:483-530.
2. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62.
3. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-1186.
4. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18.
5. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005;69(Suppl 3):4-10.
6. Zanetta L, Marcus SG, Vasile J, et al. Expression of von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Cancer 2000;85:281-288.
7. Klagsbrun M. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin Cancer Biol 1992;3:81-87.
8. Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001;7:987-989.
9. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685-693.
10. St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science 2000;289:1197-1202.
11. Hida K, Klagsbrun M. A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities. Cancer Res 2005;65:2507-2510.
12. Saunders M, Iveson T. Management of advanced colorectal cancer: state of the art. Br J Cancer 2006;95:131-138.
13. Hurwitz H, Kabbinavar F. Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer. Oncology 2005;69(Suppl 3):17-24.
14. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342.
15. Lubeseder-Martellato C, Guenzi E, Jorg A, et al. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am J Pathol 2002;161:1749-1759.
16. Naschberger E, Lubeseder-Martellato C, Meyer N, et al. Human guanylate binding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitis. Am J Pathol 2006;169:1088-1099.
17. Guenzi E, Topolt K, Cornali E, et al. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J 2001;20:5568-5577.
18. Guenzi E, Topolt K, Lubeseder-Martellato C, et al. The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J 2003;22:3772-3782.
19. Miebach S, Grau S, Hummel V, et al. Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades. J Neurooncol 2006;76:39-48.
20. Fonsatti E, Altomonte M, Nicotra MR, et al. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 2003;22:6557-6563.
21. Giddings JC, Shall L. Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin 1. Thromb Res 1987;47:259-267.
22. Damin DC, Rosito MA, Gus P, et al. Von Willebrand factor in colorectal cancer. Int J Colorectal Dis 2002;17:42-45.
23. Wang Q, Shorten D, Xu X, et al. Effect of von Willebrand factor on the pharmacokinetics of recombinant human platelet glycoprotein Ibalpha-immunoglobulin G1 chimeric proteins. Pharm Res 2006;23:1743-1749.
24. Johnson TE, Umbenhauer DR, Hill R, et al. Karyotypic and phenotypic changes during in vitro aging of human endothelial cells. J Cell Physiol 1992;150:17-27.